Tobe, Kazuyuki
Maegawa, Hiroshi
Nakamura, Ichiro
Uno, Satoshi
Funding for this research was provided by:
Astellas Pharma Inc.
Article History
Received: 21 August 2020
Accepted: 12 October 2020
First Online: 23 November 2020
Compliance with ethical standards
:
: Tobe K received lecture fees from MSD K.K., Novo Nordisk Pharma Ltd., Kowa Pharmaceutical Co. Ltd.; grants from Daiichi Sankyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Teijin Pharma Limited, Eli Lilly Japan K.K., Asahi Kasei Pharma Corporation, The Mitsubishi Foundation, and Suntory Global Innovation Center Ltd. Maegawa H has received lecture fees from MSD K.K., Sanofi K.K., Astellas Pharma Inc., Nippon Boehringer Ingelheim Co. Ltd., Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co. Ltd., Astra Zeneca K.K., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd. and Sumitomo Dainippon Pharma Co. Ltd.; research support from Astellas Pharma Inc., Astra Zeneca K.K., Nippon Boehringer Ingelheim Co. Ltd., Sunstar Inc., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Nissan Chemical Corporation and MIKI Corporation; grants from Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., MSD K.K., Nippon Boehringer Ingelheim Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kowa Pharmaceutical Co. Ltd., Taisho Pharma Co. Ltd., Ono Pharmaceutical Co. Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co. Ltd., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., Bayer Yakuhin Ltd., Teijin Pharma Limited, Shionogi & Co. Ltd., Novartis Pharma K.K. and Nipro Corporation. Nakamura I and Uno S are employees of Astellas Pharma Inc.
: This study was conducted as a special drug use surveillance study in compliance with Japanese Good Post-marketing Study Practice (GPSP) and the study protocol was approved by the Japanese government Ministry of Health, Labour and Welfare. All medical institutions that agreed to provide data signed a contract with Astellas Pharma Inc.
: Anonymous patient data were collected via electronic survey forms from clinical settings, thus it was not deemed necessary to obtain patient informed consent.
: Researchers may request access to anonymized participant level data, trial level data and protocols from Astellas sponsored clinical trials atExternalRef removed. For the Astellas criteria on data sharing see:ExternalRef removed